MRI T2高信号与硬纤维瘤观察期进展的关联:回顾性队列研究
本研究回顾性分析37例接受主动观察的硬纤维瘤患者,评估基线MRI T2高信号体积百分比与RECIST进展的关系。结果显示,T2高信号≥90%者的进展风险显著高于<90%者(HR=11.3,P=0.003),1年无进展生存率分别为55%和94%。该指标可能有助于筛选需早期干预的患者。
要点
- T2高信号≥90%者进展风险显著增加(HR=11.3,P=0.003)。
- 1年无进展生存率:≥90%组55% vs <90%组94%。
- 肿瘤大小、部位、年龄与无进展生存无关。
核心结论
- 基线MRI T2高信号体积百分比与硬纤维瘤观察期进展相关,可能帮助区分需早期干预与可安全观察的患者。
研究设计与样本
- 回顾性队列研究,从机构数据库筛选160例硬纤维瘤患者,其中72例接受主动观察,37例有连续MRI可评估。
主要发现
- 37例患者中位年龄35岁,中位肿瘤大小4.7 cm,均为腹外肿瘤(41%位于腹壁)。
- 无进展生存与肿瘤大小、部位、年龄无关,但与T2高信号≥90% vs <90%强烈相关(HR=11.3,P=0.003)。
- ≥90%组(n=20)1年无进展生存率55%,<90%组(n=17)为94%。
- 验证放射科医生定义的T2高信号百分比与测试放射科医生结果相关(ρ=0.75)。
关键数值与推荐
- T2高信号≥90% vs <90%:HR=11.3,P=0.003。
- ≥90%组1年无进展生存率55%,<90%组94%。
- 验证放射科医生与测试放射科医生评估的T2高信号百分比相关系数ρ=0.75。
临床怎么用
- 对硬纤维瘤主动观察患者,可评估基线MRI T2高信号体积百分比,≥90%者考虑更密切监测或早期干预。
局限性
- 回顾性研究,样本量较小(37例可评估),均为腹外肿瘤,需前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to identify predictors of desmoid progression during observation. SUMMARY OF BACKGROUND DATA: Untreated desmoids can grow, remain stable, or regress, but reliable predictors of behavior have not been identified. METHODS: Primary or recurrent desmoid patients were identified retrospectively from an institutional database. In those managed with active observation who underwent serial magnetic resonance imaging (MRIs) with T2-weighted sequences, baseline tumor size was recorded, and 2 radiologists independently estimated the percentage of tumor volume showing hyperintense T2 signal at baseline. Associations of clinical or radiographic characteristics with progression-free survival (PFS; by RECIST) were evaluated by Cox regression and Kaplan-Meier statistics. RESULTS: Among 160 patients with desmoids, 72 were managed with observation, and 37 of these had serial MRI available for review. Among these 37 patients, median age was 35 years and median tumor size was 4.7 cm; all tumors were extra-abdominal (41% in abdominal wall). Although PFS was not associated with size, site, or age, it was strongly associated with hyperintense T2 signal in ≥90% versus <90% of baseline tumor volume (as defined by the "test" radiologist; hazard ratio = 11.3, P = 0.003). For patients in the ≥90% group (n = 20), 1-year PFS was 55%, compared with 94% in the <90% group (n = 17). The percentage of baseline tumor volume with hyperintense T2 signal defined by a validation radiologist correlated with results of the test radiologist (ρ = 0.75). CONCLUSION: The percent tumor volume characterized by hyperintense T2 signal is associated with desmoid progression during observation and may help distinguish patients who would benefit from early intervention from those who may be reliably observed.
引用
- Cassidy MR, Lefkowitz RA, Long N, et al. Association of MRI T2 Signal Intensity With Desmoid Tumor Progression During Active Observation: A Retrospective Cohort Study. Ann Surg. 2020. PMID: 30418203. doi:10.1097/SLA.0000000000003073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。